Viral Clearance Market is Segmented By Type of Scale of Operation (Discovery Phase, Preclinical Phase, Clinical Phase), By Type of Method of Viral Cle....
Market Size in USD
CAGR10%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 10% |
Market Concentration | Medium |
Major Players | Charles River Laboratories, Creative Biolabs, Eurofins Scientific, Microbac Laboratories, MilliporeSigma |
The Viral Clearance Market is estimated to be valued at USD 0.9 Bn in 2024 and is expected to reach USD 1.7 Bn by 2031, growing at a compound annual growth rate (CAGR) of 10% from 2024 to 2031. The market has seen steady growth over the past few years driven by increasing demand for developing safe and effective biologics and therapeutics.
The market is expected to witness positive growth over the forecast period supported by rising prevalence of viral infectious diseases worldwide and increasing R&D investments in biopharmaceutical industry for drug development. Furthermore, stringent regulatory guidelines regarding safety of biotherapeutics and growing adoption of viral clearance testing during drug development and manufacturing is expected to supplement the market growth during next few years.